Tag: Turkey

WHAT`S GOING ON WITH THE TURKISH ORPHAN DRUGS MARKET?

Ankara, Turkey – Many countries and regions have already defined health policies on orphan drugs for rare diseases. Although there is no official definition in Turkey, all orphan drugs are covered by reimbursement, regardless of their market authorization status.

Posted in Announcements, Health Policy Analyses, Value in Health Regional Issues Tagged with: , , , , , , , ,

Does an Official Positive List of Medical Devices Exist?

Istanbul, Turkey – Official positive list practices revealing the reimbursement status of medical devices globally has become a significant benchmark for decision makers. Considering this fact, it is crucial to explicate whether an official positive list of reimbursed medical devices exists

Posted in Health Policy Analyses, ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: , ,

Chickenpox – An Innocent Looking Threat

Istanbul, Turkey – Varicella, the primary manifestation of a varicella zoster virus (VZV), otherwise known as chickenpox, is a highly contagious disease which occurs in all countries worldwide. Although varicella is a harmless disease in most healthy individuals, complications of the

Posted in Value in Health Regional Issues Tagged with: , , ,

How to Get into Turkey’s Medical Device Market?

Ankara, Turkey  – Despite the global economic crisis, Turkey has one of the most attractive economies due to its growing health care sector. As a result of this growth, the market for medial devices in Turkey is also growing. The 2010 figures

Posted in ISPOR CONNECTIONS, Value & Outcomes Spotlight Tagged with: , ,